ESTRO 2025 - Abstract Book

S1587

Clinical – Mixed sites & palliation

ESTRO 2025

Conclusion: This analysis highlights the need to optimize fractionation protocols to reduce treatment burden for patients with limited life expectancy and to better align treatment with palliative objectives. A local review of protocols is recommended to identify areas for improvement, such as adjusting fractionation schemes and enhancing the use of risk identification forms. Evaluating wait times is also critical, as any change may impact 30-day mortality rates. An annual audit will allow us to monitor protocol adherence and assess the impact of implemented improvements.

Keywords: Palliative, Fractionation, 30Day mortality

References: Tanya Holt, Muhammed Aashiq Rahman, Syeda Farah Zahir, Brigid Hickey. Defining the expected 30-day mortality for patients undergoing palliative radiotherapy: A meta-analysis. Radiotherapy and Oncology 168 (2022) 147 – 210.

Lees K. Audit of 30 day mortality following palliative radiotherapy. | The Royal College of Radiologists. Vols. 1-3. Accessed January 17, 2021. https://www.rcr.ac.uk/audit/audit-30-day-mortality-following-palliativeradiotherapy.

Joshua A. Jones; Stephen T. Lutz; Edward Chow; Peter A. Johnstone, FACR. Palliative Radiotherapy at the End of Life: A Critical Review. CA CANCER J CLIN 2014; 64: 296 – 310.

4301

Digital Poster Turning the pain down: Enhancing quality of life in radiation oncology inpatient department. Sofía Santana Jiménez, Irene Ávila Gómez, Peppa Abelairas Ramos, Clara Caballero Valls, Sofía Córdoba Largo, Beatriz Gil Haro, Raquel Benlloch Rodríguez, María Hernández Miguel, Marta López Valcarcel, Cristina de la Fuente Alonso, Joaquin Velasco Jiménez, Irma Zapata Paz, Sara Pérez Mata, Carlota Cascajares Sanz, Mariela Rojas Quesada, Sofía Merino Pedraza, Susana Sánchez Rico, Arancha Gallego Barranco, Jose Cantillana Barrenas, Maria Ángeles Ruíz

Rodríguez, Maria Isabel Garcia Berrocal, Jesús Romero Fernández Radiation Oncology, Puerta de hierro University Hospital, Madrid, Spain

Purpose/Objective: To analyze pain incidence, severity, treatment and quality-of-life (QoL) in oncology patients (p) in our Radiation Oncology Ward (ORTW) before admission, during stay and at discharge. Material/Methods: From July-2023 to Octubre- 2024 we conducted a prospective study in 100p with ECOG≤2 admitted to our ORTW. Patient characteristics are shown in Figure 1. Tumor stages: I (13%), II (12%), III (27%) and IV (48%). Mean age: 68y (33-90). Average hospital stay: 8d (1-43). Most frequent cause-of-admission: poor-pain-control (24%). QoL was assessed using EORTC-QLQ-C30 questionnaire. Pain was measured using visual analog scale (VAS). Additional variables analyzed included: pain characteristics, management and impact. Statistics: Paired T-test, chi-squared, Kaplan-Meier. Results: Most representative ICD-10 codes, diagnosis related groups (DRG) and other pain characteristics are shown in Figure 1. Sixty-seven patients (67%) presented pain at admission. Pain management strategies included: pharmacological treatment alone in 56p (83%) and palliative-radiotherapy in 15p (22%) with doses: 60% 20Gy; 27% 25Gy; 13% 30Gy. Mean VAS at admission was 4.04, which significantly decreased to 1.2 at discharge (p<0.01).